Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,573,656
-$9,482,424 QoQ
Shares Held
22,542
-94.7% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#101
of 239 holders
Holding Since
Mar 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. NKTR ranks #133 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in NKTR
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,573,656 | 22,542 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $11,056,080 | 427,867 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,475,776 | 3,640,851 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $774,926 | 833,256 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $652,066 | 501,590 | Shares | Other | 2024-11-14 | |
| 2024-03-31 | $400,814 | 430,983 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $803,907 | 1,435,549 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,199,758 | 3,666,264 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,636,539 | 2,821,620 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,916,620 | 2,738,029 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,000,859 | 442,858 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $706,688 | 220,840 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,898,449 | 499,592 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $981,826 | 182,157 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||